Related Experiment Video
Updated: Jun 28, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
[Signal pathway in apoptosis of K562 cells induced by STI571]
Shu-Yan Wang1, Chao-Hui Sun, Min Wei
1Department of Medical Adminstration, Guangzhou General Hospital of Guangzhou Military Area, Guangzhou, 510010, Guangdong Province, China.
Abstract:
This study was aimed to investigate the effect of tyrosine kinase inhibitor (STI571) on growth and proliferation of K562 cells by using microarray method, the changes of gene expression in the process of K562 cell apoptosis induced by STI571 and the mechanism of K562 cell apoptosis. The gene microarray probes were prepared by RD-PCR technique, then the microarray of gene expression map was constructed; the morphologic changes of K562 cells were observed under phase-contrast microscopy before and after treatment with STI571; the apoptosis of K562 cells treated with STI571 was assayed by MTT method; the expression level of genes was analyzed by self-made microarray. The results indicated that after the treatment of STI571 for 24 hours, in K562 cells appeared major morphological changes, which included nuclear shrinkage, membrane bleb and scattered apoptotic bodies. DNA gel electrophoresis also showed that the typical "DNA ladder" phenomena existed in the treated group. After hybridization, detection and analysis with microarray method, expression of 9 genes significantly down-regulated and expression of 4 genes up-regulated. These differentially expressed genes included cell cycle related genes, cell metabolizing pathway related genes, signal transduction and transcription regulation related genes and antiapoptosis genes. It is concluded that STI571 can effectively inhibit the K562 cell growth and induce K562 cell apoptosis. The genes screened from this microarray offer new information for exploration of pathogenesis of K562 cell malignant transformation and shows abundant potential targets for the treatment of CML.
Insights
The tyrosine kinase inhibitor STI571 effectively halts K562 cell growth and triggers apoptosis. Microarray analysis revealed significant gene expression changes, offering potential therapeutic targets for chronic myeloid leukemia (CML).
Area of Science:
- Cell Biology
- Molecular Biology
- Pharmacology
Context:
- K562 cells are a human chronic myeloid leukemia (CML) cell line.
- Tyrosine kinase inhibitors (TKIs) are crucial in CML treatment.
- Understanding TKI-induced apoptosis mechanisms is vital for targeted therapies.
Purpose:
- To investigate the effects of STI571 on K562 cell growth and proliferation.
- To analyze gene expression changes during STI571-induced apoptosis.
- To elucidate the molecular mechanisms underlying K562 cell apoptosis.
Summary:
- STI571 treatment induced significant morphological changes in K562 cells, indicative of apoptosis, including nuclear shrinkage and apoptotic bodies.
- DNA gel electrophoresis confirmed apoptosis via the "DNA ladder" phenomenon.
- Microarray analysis identified 9 downregulated and 4 upregulated genes, including those involved in cell cycle, metabolism, signal transduction, and apoptosis regulation.
Impact:
- STI571 demonstrates potent inhibition of K562 cell proliferation and induction of apoptosis.
- The identified differentially expressed genes provide novel insights into K562 cell pathogenesis.
- These findings highlight potential therapeutic targets for CML treatment.
More Related Videos
11:21Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy